U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07439757) titled 'AI-Powered Precision Decision-Making for Pancreatic Diseases' on Feb. 23.
Brief Summary: This multicenter clinical trial evaluates an artificial intelligence (AI) system designed to assist in the diagnosis and management of pancreatic diseases. Using contrast-enhanced CT scans, the study compares the AI's recommendations against the decisions of experienced clinicians to verify the system's accuracy and safety in a real-world setting. Patients are categorized into three management groups: Intervention (surgery/treatment), Intensive Surveillance (close monitoring), or Routine Surveillance (standard follow-up). The primary goal is to ...